Evidence map›Paper›PMID 31189917›Full record

ArticleNature communications2019

Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system.

Laura Rinaldi, Rossella Delle Donne, Bruno Catalanotti, Omar Torres-Quesada, Florian Enzler, Federica Moraca, Robert Nisticò, Francesco Chiuso, Sonia Piccinin, Verena Bachmann and 9 more

Erratum issuedOpen access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies.Movement disorders : official journal of the Movement Disorder Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Site-specific ubiquitination: Deconstructing the degradation tag.Current opinion in structural biology · 2022
    Review
  18. Article
  19. Pathophysiology of Primary Cilia: Signaling and Proteostasis Regulation.Frontiers in cell and developmental biology · 2022
    Review
  20. GPharmacological reviews · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 3 countries.

Laura RinaldiDepartment of Molecular Medicine and Medical Biotechnologies, University Federico II, 80131, Naples, Italy.
Rossella Delle DonneDepartment of Molecular Medicine and Medical Biotechnologies, University Federico II, 80131, Naples, Italy.
Bruno CatalanottiDepartment of Pharmacy, University Federico II, 80131, Naples, Italy.ORCID http://orcid.org/0000-0002-7532-6959
Omar Torres-QuesadaInstitute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, A-6020, Innsbruck, Austria.
Florian EnzlerInstitute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, A-6020, Innsbruck, Austria.
Federica MoracaDepartment of Chemical Sciences, University Federico II, 80131, Naples, Italy.ORCID http://orcid.org/0000-0002-1077-1971
Robert NisticòEuropean Brain Research Institute, Rita Levi-Montalcini Foundation and Department of Biology, University Tor Vergata, 00143, Rome, Italy.
Francesco ChiusoDepartment of Molecular Medicine and Medical Biotechnologies, University Federico II, 80131, Naples, Italy.
Sonia PiccininEuropean Brain Research Institute, Rita Levi-Montalcini Foundation and Department of Biology, University Tor Vergata, 00143, Rome, Italy.
Verena BachmannInstitute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, A-6020, Innsbruck, Austria.
Herbert H LindnerDivision of Clinical Biochemistry, Biocenter Medical University of Innsbruck, Innrain 80-82, A-6020, Innsbruck, Austria.
Corrado GarbiDepartment of Molecular Medicine and Medical Biotechnologies, University Federico II, 80131, Naples, Italy.
Antonella ScorzielloDepartment of Neuroscience, Reproductive and Odontostomatological Sciences, University Federico II, 80131, Naples, Italy.
Nicola Antonino RussoI.R.C.S., BIOGEM, Ariano Irpino, 83031, Avellino, Italy.
Matthis SynofzikDepartment of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tübingen and German Center for Neurodegenerative Diseases (DZNE), 72076, Tübingen, Germany.
Ulrich StelzlInstitute of Pharmaceutical Sciences, University of Graz and BioTechMed-Graz, 8010, Graz, Austria.ORCID http://orcid.org/0000-0003-2500-3585
Lucio AnnunziatoIRCCS SDN, 80143, Naples, Italy.
Eduard StefanInstitute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, A-6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-3650-4713
Antonio FelicielloDepartment of Molecular Medicine and Medical Biotechnologies, University Federico II, 80131, Naples, Italy. feliciel@unina.it.
Federico II University Hospital · ITUniversität Innsbruck · ATEuropean Brain Research Institute · ITBiogem · ITGerman Center for Neurodegenerative Diseases · DEInnsbruck Medical University · ATSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Graz · AT

Funding

Austrian Science Fund FWF P 22608Austrian Science Fund FWF P 27606Austrian Science Fund FWF P 30441
6 · The paper itself

Abstract

Activation of G-protein coupled receptors elevates cAMP levels promoting dissociation of protein kinase A (PKA) holoenzymes and release of catalytic subunits (PKAc). This results in PKAc-mediated phosphorylation of compartmentalized substrates that control central aspects of cell physiology. The mechanism of PKAc activation and signaling have been largely characterized. However, the modes of PKAc inactivation by regulated proteolysis were unknown. Here, we identify a regulatory mechanism that precisely tunes PKAc stability and downstream signaling. Following agonist stimulation, the recruitment of the chaperone-bound E3 ligase CHIP promotes ubiquitylation and proteolysis of PKAc, thus attenuating cAMP signaling. Genetic inactivation of CHIP or pharmacological inhibition of HSP70 enhances PKAc signaling and sustains hippocampal long-term potentiation. Interestingly, primary fibroblasts from autosomal recessive spinocerebellar ataxia 16 (SCAR16) patients carrying germline inactivating mutations of CHIP show a dramatic dysregulation of PKA signaling. This suggests the existence of a negative feedback mechanism for restricting hormonally controlled PKA activities.

Indexed as

AnimalsCyclic AMPCyclic AMP-Dependent Protein Kinase Catalytic SubunitsFeedback, PhysiologicalFibroblastsHEK293 CellsHippocampusHoloenzymesHSP70 Heat-Shock ProteinsHumansLeupeptinsMiceMice, Inbred C57BLMolecular ChaperonesPhosphorylationPrimary Cell Culturebenzyloxycarbonylleucyl-leucyl-leucine aldehydeCyclic AMPCyclic AMP-Dependent Protein Kinase Catalytic SubunitsHoloenzymesHSP70 Heat-Shock ProteinsLeupeptinsMolecular ChaperonesPurine NucleosidesSTUB1 protein, humanStub1 protein, mouseUbiquitin-Protein LigasesVER 155008

Identifiers

PMID31189917
PMCPMC6561907
OpenAlexW2951086237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.